We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-6.58%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$572M
AUM Growth
+$117M
Cap. Flow
+$164M
Cap. Flow %
28.7%
Top 10 Hldgs %
65.77%
Holding
37
New
7
Increased
17
Reduced
2
Closed
9

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$23.5M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$19.9M
3
ASND icon
Ascendis Pharma A/S
ASND
+$19.4M
4
ICLR icon
Icon
ICLR
+$15.2M
5
TEM
Tempus AI
TEM
+$14.6M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$23.1M
2
EXAS
Exact Sciences
EXAS
+$15M
3
NTRA icon
Natera
NTRA
+$13.2M
4
LEGN icon
Legend Biotech
LEGN
+$8.88M
5
SLNO
Soleno Therapeutics
SLNO
+$6.26M

Sector Composition

Rank Sector Weight
1 Healthcare 83.23%
2 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$142B
$2.02M 0.35%
4,390
– –
IMCR icon
27
Immunocore
IMCR
$1.74B
$1.4M 0.24%
46,300
– –
PCSC
28
DELISTED
Perceptive Capital Solutions
PCSC
$413K 0.07%
+37,686
New +$481K
EXAS
29
DELISTED
Exact Sciences
EXAS
– –
-147,750
Closed -$15M
IRON icon
30
Disc Medicine
IRON
$3.12B
– –
-27,100
Closed -$2.15M
LEGN icon
31
Legend Biotech
LEGN
$4.22B
– –
-408,652
Closed -$8.88M
MLTX icon
32
MoonLake Immunotherapeutics
MLTX
$1.41B
– –
-187,600
Closed -$2.47M
NBIX icon
33
Neurocrine Biosciences
NBIX
$16.5B
– –
-162,800
Closed -$23.1M
PRAX icon
34
Praxis Precision Medicines
PRAX
$10.3B
– –
-14,951
Closed -$4.41M
QURE icon
35
uniQure
QURE
$3.12B
– –
-205,247
Closed -$4.91M
SLNO
36
DELISTED
Soleno Therapeutics
SLNO
– –
-135,100
Closed -$6.26M
VIR icon
37
Vir Biotechnology
VIR
$1.51B
– –
-240,500
Closed -$1.45M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q1 2026 Portfolio in Review

As of Q1 2026, Eagle Health Investments held 37 positions worth $572M, up 26% from $455M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Eagle Health Investments deployed $164M of net new capital in Q1 2026, opening 7 new positions and adding to 17 existing holdings. Its largest new stake was Boston Scientific: 293,152 shares worth $18.4M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 100% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Natera, an estimated $13.2M trimmed.

  • Eagle Health Investments's largest Q1 2026 buy was Boston Scientific: 293,152 shares worth $18.4M.
  • Eagle Health Investments added most to Icon in Q1 2026, an estimated $15.2M increase.
  • Eagle Health Investments's biggest Q1 2026 reduction was Natera, cutting an estimated $13.2M.
  • Eagle Health Investments fully exited Neurocrine Biosciences in Q1 2026, selling an estimated $23.1M.
  • Eagle Health Investments's ten largest holdings make up 66% of its $572M portfolio in Q1 2026.
  • Eagle Health Investments opened 7 new positions and closed 9 in Q1 2026.
  • Eagle Health Investments's portfolio value rose 26% quarter-over-quarter to $572M.

Based on Eagle Health Investments's 13F filing for Q1 2026, filed 15 May 2026.